Skip to main content

Table 2 Treatment and outcome of patients with SPTCL

From: A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?

 

Group 1

Group 2

p

First-line treatment, n (%)

7(41.2)

10(58.8)

 

Age, years, median

10.8

8.7

0.38

Sex, n1/n2

4/3

6/4

0.99

B symptom, n (%)

5/7(71.4)

6/10(60.0)

0.99

Haemophagocytic syndrome, n (%)

6/7(85.7)

1/10(10.0)

0.004

Complete remission, n (%)

6/7(85.7)

8/10(80.0)

0.99

Deceased, n (%)

0/7(0)

1/10(10.0)

0.99

  1. Group 1: Immunomodulator therapy; Group 2: Polychemotherapy; n1 = Male; n2 = Female